Retigabine CAS: 150812-12-7
| Product Parameters | |
|---|---|
| Catalog No. | BA06S3 |
| CAS.RN | 150812-12-7 |
| Molecular Formula | C16H18FN3O2 |
| Molecular Weight | 303.33 g/mol |
| Purity | NLT 98% |
Product Overview
Retigabine is an organic compound with antiepileptic activity, widely used in drug development and production in the field of neuroscience. As an active pharmaceutical ingredient (API), it is positioned as a key intermediate for the treatment of central nervous system diseases, suitable for all stages of drug development, from small-scale preparation to pilot-scale amplification and commercial production. This product has significant value in the development of antiepileptic drugs, meeting the needs of various synthetic routes, and is one of the important raw materials in the pharmaceutical and chemical industries.
Applications
- Synthesis of antiepileptic drugs
- Research on central nervous system diseases
- Development of pharmaceutical intermediates
- Preparation of neuromodulatory drugs
- Custom pharmaceutical synthesis services
Quality & Supply Capability
English Name: Retigabine Properties: This product is a white to off-white crystalline powder with good thermal and chemical stability. The molecule contains amino and ketone functional groups, exhibiting typical amide structural characteristics, making it suitable for various organic synthesis reactions. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific requirements. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging Documentation Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust the supply plan according to the customer's specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. Simultaneously, we have a professional technical support team to assist customers in process development, route optimization, and project transformation, ensuring that the product efficiently and stably meets the application needs at different stages.
Why Choose Bioncan
Focused on APIs, specializing in intermediates for antiepileptic drugs Full-scale supply capabilities, covering all stages from laboratory to commercial production Provides complete quality control documentation to ensure product quality compliance and reliability Supports customized needs, adjusting purity, impurity standards, and packaging as required Offers comprehensive process optimization technical support to help clients achieve efficient commercialization and project implementation
Intermediates of Retigabine
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA06S3 | Retigabine API | 150812-12-7 |
| BK66RR | 2-Amino-5-[(4-fluorobenzyl)amino]-1-nitrobenzene | 150812-21-8 |
| BK9Z31 | Retigabine Dihydrochloride | 150812-13-8 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 150812-12-7, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.